Early Response of Prostate Carcinoma Xenografts to Docetaxel Chemotherapy Monitored With Diffusion MRI

Early Response of Prostate Carcinoma Xenografts to Docetaxel Chemotherapy Monitored With Diffusion MRI

For many anticancer therapies, it would be desirable to accurately monitor and quantify tumor response early in the treatment regimen. This would allow oncologists to continue effective therapies or discontinue ineffective therapies early in the course of treatment, and hence, reduce morbidity. This...

Full description

Bibliographic Details
Main Authors: Dominique Jennings, B. Nicholas Hatton, Jingyu Guo, Jean-Philippe Galons, Theodore P. Trouard, Natarajan Raghunand, James Marshall, Robert J. Gillies
Format: Article
Language:English
Published: Elsevier 2002-01-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
diffusion-weighted MRI
apparent diffusion coefficient
prostate-specific antigen
docetaxel
prostate carcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558602800197

Internet

http://www.sciencedirect.com/science/article/pii/S1476558602800197

Similar Items